PharmaShots | Incisive News in 3 Shots

Subscribe Now

Oncopeptides

Oncopeptides’ Pepaxti (melphalan flufenamide) Receives the EC’s Approval for the Treatment of Multiple Myeloma

Oncopeptides’ Pepaxti (melphalan flufenamide) Receives the EC’s Approval for the Treatment of Multiple Myeloma

August 18, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us